Literature DB >> 22185974

Tacrolimus-induced thrombotic microangiopathy: natural history of a severe, acute vasculopathy.

John M Carson1, Eric D Newman, John L Farber, Edward J Filippone.   

Abstract

Calcineurin inhibitors (CNI) have been clearly associated with posttransplant thrombotic microangiopathy (PTTMA). We report a case of de novo PT-TMA involving predominantly small arteries and arterioles of a renal allograft in a patient receiving tacrolimus. Serial biopsies demonstrate the natural history of this lesion through the chronic nonspecific phase. The case is discussed in the context of a literature review of PT-TMA in general and CNI use in particular.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22185974     DOI: 10.5414/cn107036

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Metastatic lung adenocarcinoma- associated thrombotic microangiopathy in a renal transplant recipient.

Authors:  Eswari Vilayur; Jillian de Malmanche; Paul Trevillian; David Ferreira
Journal:  BMJ Case Rep       Date:  2018-12-13

2.  Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.

Authors:  Haruomi Nishio; Tatsuo Tsukamoto; Takeshi Matsubara; Yoichiro Okada; Ryosuke Takahashi; Motoko Yanagita
Journal:  CEN Case Rep       Date:  2016-06-20

Review 3.  Transplant glomerulopathy.

Authors:  Edward J Filippone; Peter A McCue; John L Farber
Journal:  Mod Pathol       Date:  2017-10-13       Impact factor: 7.842

Review 4.  The specificity of acute and chronic microvascular alterations in renal allografts.

Authors:  Edward J Filippone; John L Farber
Journal:  Clin Transplant       Date:  2013-10-01       Impact factor: 2.863

Review 5.  Drug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians.

Authors:  Muhammad Abdul Mabood Khalil; Muhammad Ashhad Ullah Khalil; Taqi F Taufeeq Khan; Jackson Tan
Journal:  J Transplant       Date:  2018-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.